It has been previously documented that disruption of mucosal barrier function occurs in ME/CFS as demonstrated by the increased serum concentrations of IgA and IgM to LPS of Gram-negative enterobacteria [19]. This evidence concerns the gene CD79A and myalgic encephalomeyelitis/chronic fatigue syndrome.